The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization

We conducted a case-control study to investigate whether vascular endothelial growth factor (VEGF -2578, -1154, -634, and 936) and kinase insert domain containing receptor (KDR -604, 1192, and 1719) polymorphisms are associated with moyamoya disease. Korean patients with moyamoya disease (n = 107, m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2012-10, Vol.7 (10), p.e47158-e47158
Hauptverfasser: Park, Young Seok, Jeon, Young Joo, Kim, Hyun Seok, Chae, Kyu Young, Oh, Seung-Hun, Han, In Bo, Kim, Hyun Sook, Kim, Won-Chan, Kim, Ok-Joon, Kim, Tae Gon, Choi, Joong-Uhn, Kim, Dong-Seok, Kim, Nam Keun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e47158
container_issue 10
container_start_page e47158
container_title PloS one
container_volume 7
creator Park, Young Seok
Jeon, Young Joo
Kim, Hyun Seok
Chae, Kyu Young
Oh, Seung-Hun
Han, In Bo
Kim, Hyun Sook
Kim, Won-Chan
Kim, Ok-Joon
Kim, Tae Gon
Choi, Joong-Uhn
Kim, Dong-Seok
Kim, Nam Keun
description We conducted a case-control study to investigate whether vascular endothelial growth factor (VEGF -2578, -1154, -634, and 936) and kinase insert domain containing receptor (KDR -604, 1192, and 1719) polymorphisms are associated with moyamoya disease. Korean patients with moyamoya disease (n = 107, mean age, 20.9±15.9 years; 66.4% female) and 243 healthy control subjects (mean age, 23.0±16.1 years; 56.8% female) were included. The subjects were divided into pediatric and adult groups. Among the 64 surgical patients, we evaluated collateral vessel formation after 2 years and divided patients into good (collateral grade A) or poor (collateral grade B and C) groups. The frequencies and distributions of four VEGF (-2578, -1154, -634, and 936) and KDR (-604, 1192, and 1719) polymorphisms were assessed from patients with moyamoya disease and compared to the control group. No differences were observed in VEGF -2578, -1154, -634, and 936 or KDR -604, 1192, and 1719 polymorphisms between the control group and moyamoya disease group. However, we found the -634CC genotype occurred less frequently in the pediatric moyamoya group (p = 0.040) whereas the KDR -604C/1192A/1719T haplotype increased the risk of pediatric moyamoya (p = 0.024). Patients with the CC genotype of VEGF -634 had better collateral vessel formation after surgery. Our results suggest that the VEGF -634G allele is associated with pediatric moyamoya disease and poor collateral vessel formation.
doi_str_mv 10.1371/journal.pone.0047158
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1326560873</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A498259656</galeid><doaj_id>oai_doaj_org_article_34f6afca5b21423697bf5497b729a7b2</doaj_id><sourcerecordid>A498259656</sourcerecordid><originalsourceid>FETCH-LOGICAL-c758t-1ec1bd39268f05f96cdf44305a06cbfb685d5c442a32fb087c715fe6a0b80ca53</originalsourceid><addsrcrecordid>eNqNk1tv0zAUxyMEYqPwDRBEQkLw0OJL7CQvSNNuVEyaNMZeeLBOHLt15cTFTia6T4-7ZlOD9oAsX2T_zt8-x-ckyVuMZpjm-MvK9b4FO1u7Vs0QynLMimfJIS4pmXKC6PO99UHyKoQVQowWnL9MDghFec44OUx-XS9V6p1VqdPpzen5WQptnX4_uUrXzm4a59dLE5qQmjZt3Aa2Pa1NUBDUPSmdtdApDzb16haC7C14cwedce3r5IUGG9SbYZ4kP89Or4-_TS8uz-fHRxdTmbOim2IlcVXTkvBCI6ZLLmudZRQxQFxWuuIFq5nMMgKU6AoVuYyuasUBVQWSwOgkeb_TXVsXxBCXIDAlnPHI00jMd0TtYCXW3jTgN8KBEfcbzi8E-M5IqwTNNAcdZSuCM0J5mVeaZXHMSQl5RaLW1-G2vmpULVXbRe9HouOT1izFwt1G5Ryx-JpJ8mkQ8O53r0InGhOkinFslevjuzGmZYHKDEf0wz_o094N1AKiA6bVLt4rt6LiKCsLwspIRmr2BBVbrRojYxJpE_dHBp9HBpHp1J9uAX0IYv7j6v_Zy5sx-3GPXSqw3TI4229TJozBbAdK70LwSj8GGSOxrYGHaIhtDYihBqLZu_0PejR6SHr6F5lQATE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1326560873</pqid></control><display><type>article</type><title>The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Park, Young Seok ; Jeon, Young Joo ; Kim, Hyun Seok ; Chae, Kyu Young ; Oh, Seung-Hun ; Han, In Bo ; Kim, Hyun Sook ; Kim, Won-Chan ; Kim, Ok-Joon ; Kim, Tae Gon ; Choi, Joong-Uhn ; Kim, Dong-Seok ; Kim, Nam Keun</creator><contributor>Arumugam, Thiruma V.</contributor><creatorcontrib>Park, Young Seok ; Jeon, Young Joo ; Kim, Hyun Seok ; Chae, Kyu Young ; Oh, Seung-Hun ; Han, In Bo ; Kim, Hyun Sook ; Kim, Won-Chan ; Kim, Ok-Joon ; Kim, Tae Gon ; Choi, Joong-Uhn ; Kim, Dong-Seok ; Kim, Nam Keun ; Arumugam, Thiruma V.</creatorcontrib><description>We conducted a case-control study to investigate whether vascular endothelial growth factor (VEGF -2578, -1154, -634, and 936) and kinase insert domain containing receptor (KDR -604, 1192, and 1719) polymorphisms are associated with moyamoya disease. Korean patients with moyamoya disease (n = 107, mean age, 20.9±15.9 years; 66.4% female) and 243 healthy control subjects (mean age, 23.0±16.1 years; 56.8% female) were included. The subjects were divided into pediatric and adult groups. Among the 64 surgical patients, we evaluated collateral vessel formation after 2 years and divided patients into good (collateral grade A) or poor (collateral grade B and C) groups. The frequencies and distributions of four VEGF (-2578, -1154, -634, and 936) and KDR (-604, 1192, and 1719) polymorphisms were assessed from patients with moyamoya disease and compared to the control group. No differences were observed in VEGF -2578, -1154, -634, and 936 or KDR -604, 1192, and 1719 polymorphisms between the control group and moyamoya disease group. However, we found the -634CC genotype occurred less frequently in the pediatric moyamoya group (p = 0.040) whereas the KDR -604C/1192A/1719T haplotype increased the risk of pediatric moyamoya (p = 0.024). Patients with the CC genotype of VEGF -634 had better collateral vessel formation after surgery. Our results suggest that the VEGF -634G allele is associated with pediatric moyamoya disease and poor collateral vessel formation.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0047158</identifier><identifier>PMID: 23077562</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Adolescent ; Adult ; Asian Continental Ancestry Group - genetics ; Biology ; Carotid Arteries - metabolism ; Carotid Arteries - physiopathology ; Case-Control Studies ; Child ; Child, Preschool ; Chromosomes ; Disease control ; Female ; Genetic aspects ; Genetic polymorphisms ; Haplotypes ; Humans ; Kinases ; Male ; Medicine ; Moyamoya disease ; Moyamoya Disease - genetics ; Moyamoya Disease - physiopathology ; Neovascularization, Physiologic ; Patients ; Physicians ; Physiological aspects ; Polymorphism, Single Nucleotide ; Quality ; Risk factors ; Rodents ; Surgery ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - genetics ; Vascular Endothelial Growth Factor Receptor-2 - genetics ; Young Adult</subject><ispartof>PloS one, 2012-10, Vol.7 (10), p.e47158-e47158</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>Park et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2012 Park et al 2012 Park et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c758t-1ec1bd39268f05f96cdf44305a06cbfb685d5c442a32fb087c715fe6a0b80ca53</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470587/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470587/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23077562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Arumugam, Thiruma V.</contributor><creatorcontrib>Park, Young Seok</creatorcontrib><creatorcontrib>Jeon, Young Joo</creatorcontrib><creatorcontrib>Kim, Hyun Seok</creatorcontrib><creatorcontrib>Chae, Kyu Young</creatorcontrib><creatorcontrib>Oh, Seung-Hun</creatorcontrib><creatorcontrib>Han, In Bo</creatorcontrib><creatorcontrib>Kim, Hyun Sook</creatorcontrib><creatorcontrib>Kim, Won-Chan</creatorcontrib><creatorcontrib>Kim, Ok-Joon</creatorcontrib><creatorcontrib>Kim, Tae Gon</creatorcontrib><creatorcontrib>Choi, Joong-Uhn</creatorcontrib><creatorcontrib>Kim, Dong-Seok</creatorcontrib><creatorcontrib>Kim, Nam Keun</creatorcontrib><title>The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>We conducted a case-control study to investigate whether vascular endothelial growth factor (VEGF -2578, -1154, -634, and 936) and kinase insert domain containing receptor (KDR -604, 1192, and 1719) polymorphisms are associated with moyamoya disease. Korean patients with moyamoya disease (n = 107, mean age, 20.9±15.9 years; 66.4% female) and 243 healthy control subjects (mean age, 23.0±16.1 years; 56.8% female) were included. The subjects were divided into pediatric and adult groups. Among the 64 surgical patients, we evaluated collateral vessel formation after 2 years and divided patients into good (collateral grade A) or poor (collateral grade B and C) groups. The frequencies and distributions of four VEGF (-2578, -1154, -634, and 936) and KDR (-604, 1192, and 1719) polymorphisms were assessed from patients with moyamoya disease and compared to the control group. No differences were observed in VEGF -2578, -1154, -634, and 936 or KDR -604, 1192, and 1719 polymorphisms between the control group and moyamoya disease group. However, we found the -634CC genotype occurred less frequently in the pediatric moyamoya group (p = 0.040) whereas the KDR -604C/1192A/1719T haplotype increased the risk of pediatric moyamoya (p = 0.024). Patients with the CC genotype of VEGF -634 had better collateral vessel formation after surgery. Our results suggest that the VEGF -634G allele is associated with pediatric moyamoya disease and poor collateral vessel formation.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Asian Continental Ancestry Group - genetics</subject><subject>Biology</subject><subject>Carotid Arteries - metabolism</subject><subject>Carotid Arteries - physiopathology</subject><subject>Case-Control Studies</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Chromosomes</subject><subject>Disease control</subject><subject>Female</subject><subject>Genetic aspects</subject><subject>Genetic polymorphisms</subject><subject>Haplotypes</subject><subject>Humans</subject><subject>Kinases</subject><subject>Male</subject><subject>Medicine</subject><subject>Moyamoya disease</subject><subject>Moyamoya Disease - genetics</subject><subject>Moyamoya Disease - physiopathology</subject><subject>Neovascularization, Physiologic</subject><subject>Patients</subject><subject>Physicians</subject><subject>Physiological aspects</subject><subject>Polymorphism, Single Nucleotide</subject><subject>Quality</subject><subject>Risk factors</subject><subject>Rodents</subject><subject>Surgery</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><subject>Vascular Endothelial Growth Factor Receptor-2 - genetics</subject><subject>Young Adult</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1tv0zAUxyMEYqPwDRBEQkLw0OJL7CQvSNNuVEyaNMZeeLBOHLt15cTFTia6T4-7ZlOD9oAsX2T_zt8-x-ckyVuMZpjm-MvK9b4FO1u7Vs0QynLMimfJIS4pmXKC6PO99UHyKoQVQowWnL9MDghFec44OUx-XS9V6p1VqdPpzen5WQptnX4_uUrXzm4a59dLE5qQmjZt3Aa2Pa1NUBDUPSmdtdApDzb16haC7C14cwedce3r5IUGG9SbYZ4kP89Or4-_TS8uz-fHRxdTmbOim2IlcVXTkvBCI6ZLLmudZRQxQFxWuuIFq5nMMgKU6AoVuYyuasUBVQWSwOgkeb_TXVsXxBCXIDAlnPHI00jMd0TtYCXW3jTgN8KBEfcbzi8E-M5IqwTNNAcdZSuCM0J5mVeaZXHMSQl5RaLW1-G2vmpULVXbRe9HouOT1izFwt1G5Ryx-JpJ8mkQ8O53r0InGhOkinFslevjuzGmZYHKDEf0wz_o094N1AKiA6bVLt4rt6LiKCsLwspIRmr2BBVbrRojYxJpE_dHBp9HBpHp1J9uAX0IYv7j6v_Zy5sx-3GPXSqw3TI4229TJozBbAdK70LwSj8GGSOxrYGHaIhtDYihBqLZu_0PejR6SHr6F5lQATE</recordid><startdate>20121012</startdate><enddate>20121012</enddate><creator>Park, Young Seok</creator><creator>Jeon, Young Joo</creator><creator>Kim, Hyun Seok</creator><creator>Chae, Kyu Young</creator><creator>Oh, Seung-Hun</creator><creator>Han, In Bo</creator><creator>Kim, Hyun Sook</creator><creator>Kim, Won-Chan</creator><creator>Kim, Ok-Joon</creator><creator>Kim, Tae Gon</creator><creator>Choi, Joong-Uhn</creator><creator>Kim, Dong-Seok</creator><creator>Kim, Nam Keun</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20121012</creationdate><title>The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization</title><author>Park, Young Seok ; Jeon, Young Joo ; Kim, Hyun Seok ; Chae, Kyu Young ; Oh, Seung-Hun ; Han, In Bo ; Kim, Hyun Sook ; Kim, Won-Chan ; Kim, Ok-Joon ; Kim, Tae Gon ; Choi, Joong-Uhn ; Kim, Dong-Seok ; Kim, Nam Keun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c758t-1ec1bd39268f05f96cdf44305a06cbfb685d5c442a32fb087c715fe6a0b80ca53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Asian Continental Ancestry Group - genetics</topic><topic>Biology</topic><topic>Carotid Arteries - metabolism</topic><topic>Carotid Arteries - physiopathology</topic><topic>Case-Control Studies</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Chromosomes</topic><topic>Disease control</topic><topic>Female</topic><topic>Genetic aspects</topic><topic>Genetic polymorphisms</topic><topic>Haplotypes</topic><topic>Humans</topic><topic>Kinases</topic><topic>Male</topic><topic>Medicine</topic><topic>Moyamoya disease</topic><topic>Moyamoya Disease - genetics</topic><topic>Moyamoya Disease - physiopathology</topic><topic>Neovascularization, Physiologic</topic><topic>Patients</topic><topic>Physicians</topic><topic>Physiological aspects</topic><topic>Polymorphism, Single Nucleotide</topic><topic>Quality</topic><topic>Risk factors</topic><topic>Rodents</topic><topic>Surgery</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><topic>Vascular Endothelial Growth Factor Receptor-2 - genetics</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Park, Young Seok</creatorcontrib><creatorcontrib>Jeon, Young Joo</creatorcontrib><creatorcontrib>Kim, Hyun Seok</creatorcontrib><creatorcontrib>Chae, Kyu Young</creatorcontrib><creatorcontrib>Oh, Seung-Hun</creatorcontrib><creatorcontrib>Han, In Bo</creatorcontrib><creatorcontrib>Kim, Hyun Sook</creatorcontrib><creatorcontrib>Kim, Won-Chan</creatorcontrib><creatorcontrib>Kim, Ok-Joon</creatorcontrib><creatorcontrib>Kim, Tae Gon</creatorcontrib><creatorcontrib>Choi, Joong-Uhn</creatorcontrib><creatorcontrib>Kim, Dong-Seok</creatorcontrib><creatorcontrib>Kim, Nam Keun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Park, Young Seok</au><au>Jeon, Young Joo</au><au>Kim, Hyun Seok</au><au>Chae, Kyu Young</au><au>Oh, Seung-Hun</au><au>Han, In Bo</au><au>Kim, Hyun Sook</au><au>Kim, Won-Chan</au><au>Kim, Ok-Joon</au><au>Kim, Tae Gon</au><au>Choi, Joong-Uhn</au><au>Kim, Dong-Seok</au><au>Kim, Nam Keun</au><au>Arumugam, Thiruma V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-10-12</date><risdate>2012</risdate><volume>7</volume><issue>10</issue><spage>e47158</spage><epage>e47158</epage><pages>e47158-e47158</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>We conducted a case-control study to investigate whether vascular endothelial growth factor (VEGF -2578, -1154, -634, and 936) and kinase insert domain containing receptor (KDR -604, 1192, and 1719) polymorphisms are associated with moyamoya disease. Korean patients with moyamoya disease (n = 107, mean age, 20.9±15.9 years; 66.4% female) and 243 healthy control subjects (mean age, 23.0±16.1 years; 56.8% female) were included. The subjects were divided into pediatric and adult groups. Among the 64 surgical patients, we evaluated collateral vessel formation after 2 years and divided patients into good (collateral grade A) or poor (collateral grade B and C) groups. The frequencies and distributions of four VEGF (-2578, -1154, -634, and 936) and KDR (-604, 1192, and 1719) polymorphisms were assessed from patients with moyamoya disease and compared to the control group. No differences were observed in VEGF -2578, -1154, -634, and 936 or KDR -604, 1192, and 1719 polymorphisms between the control group and moyamoya disease group. However, we found the -634CC genotype occurred less frequently in the pediatric moyamoya group (p = 0.040) whereas the KDR -604C/1192A/1719T haplotype increased the risk of pediatric moyamoya (p = 0.024). Patients with the CC genotype of VEGF -634 had better collateral vessel formation after surgery. Our results suggest that the VEGF -634G allele is associated with pediatric moyamoya disease and poor collateral vessel formation.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23077562</pmid><doi>10.1371/journal.pone.0047158</doi><tpages>e47158</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2012-10, Vol.7 (10), p.e47158-e47158
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1326560873
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Adolescent
Adult
Asian Continental Ancestry Group - genetics
Biology
Carotid Arteries - metabolism
Carotid Arteries - physiopathology
Case-Control Studies
Child
Child, Preschool
Chromosomes
Disease control
Female
Genetic aspects
Genetic polymorphisms
Haplotypes
Humans
Kinases
Male
Medicine
Moyamoya disease
Moyamoya Disease - genetics
Moyamoya Disease - physiopathology
Neovascularization, Physiologic
Patients
Physicians
Physiological aspects
Polymorphism, Single Nucleotide
Quality
Risk factors
Rodents
Surgery
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - genetics
Vascular Endothelial Growth Factor Receptor-2 - genetics
Young Adult
title The role of VEGF and KDR polymorphisms in moyamoya disease and collateral revascularization
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A30%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20VEGF%20and%20KDR%20polymorphisms%20in%20moyamoya%20disease%20and%20collateral%20revascularization&rft.jtitle=PloS%20one&rft.au=Park,%20Young%20Seok&rft.date=2012-10-12&rft.volume=7&rft.issue=10&rft.spage=e47158&rft.epage=e47158&rft.pages=e47158-e47158&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0047158&rft_dat=%3Cgale_plos_%3EA498259656%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1326560873&rft_id=info:pmid/23077562&rft_galeid=A498259656&rft_doaj_id=oai_doaj_org_article_34f6afca5b21423697bf5497b729a7b2&rfr_iscdi=true